1 / 12

Clinical trial protocol writing

u2022The clinical study protocol is defined as the procedures by which clinical research is conducted<br>u2022A clinical study protocol should provide a clear clinical study design to meet the objective of the clinical trial<br>u2022tA defined protocol must address the proposed medical question and protect the safety and rights of the clinical trial participant/patients<br> To Continue Reading : https://bit.ly/2W5AgGu<br><br>Contact Us:<br>Website : https://bit.ly/33Fwsye<br>Email us: sales.cro@pepgra.com<br>Whatsapp: 91 9884350006<br>

pepgra
Download Presentation

Clinical trial protocol writing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CLINICALTRIALPROTOCOL WRITING:CHALLENGES ANDGUIDELINES AnAcademicpresentation by Dr.NancyAgens,Head,TechnicalOperations, Pepgra Group:www.pepgra.com Email:pepgrahealthcare@gmail.com

  2. Today'sDiscussion OUTLINEOFTOPICS InBrief Introduction ChallengesinWritingClinicalProtocol GeneralGuidelinesin Writingthe Clinical ProtocolConclusion

  3. InBrief Theclinicalstudyprotocolisdefinedastheproceduresbywhichclinicalresearchisconducted.Aclinicalstudyprotocolshouldprovideaclearclinicalstudydesigntomeettheobjectiveofthe clinicaltrial.Adefinedprotocolmustaddresstheproposedmedicalquestionandprotectthesafetyandrightsoftheclinical trialparticipant/patients.

  4. Introduction Clinicaltrialsareaimedatevaluatingnewpharmaceuticaldrugs,medicaldevices, andsurgicalmaterials. Clinicaltrialsarealsoconductedindiagnosingdiseasesearlytopreventtheseverityofthediseaseconditions. Everynewfindingofmedicaldrugsanddevicesgoesthroughfourphasesofclinicaltrialstofindtheappropriatedosagevalueandthecorrespondingsideeffects. PhaseI:Theclinicaltrialexperimentswillbecarriedoutwithasmallgroupof participantstestthesafetyandsideeffectstofindtheaccuratedosagevalue. Contd..

  5. PhaseII:Testingtheeffectivenessandobtainpreliminarydataofcuringrateandstudytheshort-termsideeffects.PhaseII:Testingtheeffectivenessandobtainpreliminarydataofcuringrateandstudytheshort-termsideeffects. PhaseIII:Thedrugwillbetestedinalargegrouptocollectmoredataonsafety,effectiveness,sideeffectsrelatedtodosagerangewithdifferentagegroupsanddiseaseseverity. PhaseIV:Willbepermittedtocarryoutwithadiversepopulationforaprolongedperiodforadetailedstudy.

  6. ChallengesinWritingClinicalProtocol Theclinicaltrialprotocolisawell-definedprocedureofthestudy,anditmustprovideaclear&concisedesigntomeettheobjectiveofthestudy. Thecontributionsofmedicalexperts,regulatoryexperts,statisticians,pharmacokineticistsandoperationalexpertsaremandatoryinprotocoldevelopment. Writingawell-communicatedclinicaltrialprotocolisoftenchallenging,andInternationalCouncilforHarmonisationGoodClinicalPracticeprovidedcertainrecommendationlikewhatneedstobeincludedintheprotocolanditsstructure.

  7. GeneralGuidelinesinWritingtheClinicalProtocol 1.INTRODUCTION: Theintroductionmusthavedetailedliteraturereviewcoveringtheexistingtherapeuticoptionsandtestmethods. 2.OBJECTIVE: Thissectionshouldstatetheobjectiveintheform"SMART". Therearethreecategoriestheyareprimary,secondaryandexploratory. Primarywilldelivertheaimstoanswerclinicaltrialpurposedirectly. Secondarywillexplaintheassociatedactionswiththerationale. Contd..

  8. Exploratorywillstatethehypothesis-generatingobjectivesthatcanbeanalysedwithadditionalstudies.Exploratorywillstatethehypothesis-generatingobjectivesthatcanbeanalysedwithadditionalstudies. Figure1:Smart Contd..

  9. 3.POPULATION: Thetargetedpopulationwillbeusedforthetrialincludesthegeographicalregionandadetailedlistofinclusionandexclusioncriteriawhichspecifiesage,sex,BMI,etc. 4.ENDPOINTS: Itisdefinedasanindicatorinmeasuringabiologicalsample. Thereshouldbeanendpointwhichexactlymatchestheobjectiveofthestudyto ensurethatthecorrectvariablesaremeasured. 5.TRIALDESIGN: Theclinicaltrialdesignwillindicatetheparticipant'streatmentandthenumberofrequiredgroupsfortreatmentanddatacollections. Contd..

  10. 6.CONTROLGROUPS: Thissectionexplainsthecontrolgroupsandthetargetpopulationshouldbeclearlyidentifiedandjustified,andthecontrolgroupmustbealignedwiththeclinicaltrialdesignandobjective. 7.STATISTICALCONSIDERATIONS: Thissectionintheprotocolshouldexplaintherationaleforthecalculatedsamplesizewiththeclinicalandstatisticalassumptionsbasedontheprimaryendpoint. Weprovidestatisticiansupport,andwhenapplicableweofferothersupport,andwehaveexpertslikepharmacodynamicsexpertsandclinicalwritingexpert.

  11. Conclusion Theclinicalprotocolistheprocedurebywhichthetrial isconducted,andthewritingrequiresawideamountofassessmentonallconcepts relatedtothetrial. Pepgrahasunderstoodthecomplexityofdevelopingacomplete clinical trialprotocolwithexperts. Ourteam ofexpertswillthusprotectthescientificintegrityofthetrial andthesafetyoftheparticipants.

  12. ContactUs UNITEDKINGDOM +44-7424810299 INDIA +91-9884350006 EMAIL pepgrahealthcare@gmail.com

More Related